Simulations Plus

Simulations Plus Net Margin

The Net Profit Margin of Simulations Plus (SLP) as of Sep 27, 2026 is -81.74 %. In the previous year, Net Profit Margin was 14.22 % — a change of -674.91% (lower).

Net Margin

-81.74 %

YoY

-674.91%

Last updated:

Net Profit Margin of Simulations Plus is 2026 -81.74 % . Net Profit Margin of Simulations Plus was 2025 14.22 % . It decreases by -674.91% lower compared to the previous year.

For Simulations Plus, the net margin of -81.7% is down versus 21.1% a few years ago.

The Simulations Plus Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
30.12 USD
Jan 1, 2019
25.27 USD
Jan 1, 2020
22.44 USD
Jan 1, 2021
21.05 USD
Jan 1, 2022
23.16 USD
Jan 1, 2023
16.72 USD
Jan 1, 2024
14.22 USD
Jan 1, 2025
-81.74 USD
The Simulations Plus Net Margin history
YEARNet MarginYoY
-81.74 %-674.91%
14.22 %-14.97%
16.72 %-27.80%
23.16 %+10.00%
21.05 %-6.18%
22.44 %-11.19%
25.27 %-16.11%
30.12 %+25.61%
23.98 %-3.26%
24.79 %+18.12%
20.98 %-20.51%
26.40 %+9,109.89%
0.29 %-10.56%
0.32 %+3.16%
0.31 %+54.33%
0.20 %+30.33%
0.15 %-19.74%
0.19 %+16.25%
0.17 %+43.39%
0.12 %—
Access this data via the Eulerpool API
Get Free API Key

Simulations Plus Stock analysis

What does Simulations Plus do? Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Simulations Plus stock

Net Profit Margin of Simulations Plus is -81.74 % in 2026.

Net Profit Margin of Simulations Plus changed from 14.22 % to -81.74 %, representing a -674.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Simulations Plus since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Simulations Plus with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API
Get Free API Key

Margins — Simulations Plus

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Simulations Plus